ABSTRACT
The lengthy, complex, and costly process enclosed with a high degree of uncertainty that a drug will gain market approval are challenges in drug discovery and development. With high-throughput screening and computational methods, computer-aided drug discovery can accelerate the lengthy and costly processes. The predatory cone snails of the genus Conus are specialists in neuropharmacology. In the Philippines, C. textile is reported to inhabit the tropical waters of the islands. Their conopeptide-rich venom can serve as repertoires of potential drug candidates for distinct diseases. Although isolation and activity studies have been conducted, most are tested in animal models only, and there are important distinctions between a human patient and animal prey. To investigate their human therapeutics application, we acquired the 3D structures of the conopeptides, target receptors, natural ligands, and FDA-approved drugs. We conducted a binding affinity and ligand-receptor interaction analysis. Results showed that Conorfamide Tx-1, Contryphan TxR, alpha-conotoxin TxIA, and epsilon-conotoxin TxVA have superior binding affinity compared to the target receptor's endogenous and FDA-approved drug ligand. However, conopressin and delta-conotoxin TxVIA have lower binding affinities than the positive controls. Important key residue interactions that affect binding affinities were identified that can guide future studies in peptide modification.
- Rita C. Acúrcio, Anna Scomparin, Ronit Satchi‐Fainaro, Helena F. Florindo, and Rita C. Guedes. 2019. Computer‐aided drug design in new druggable targets for the next generation of immune‐oncology therapies. Wiley Interdiscip Rev Comput Mol Sci 9, 3 (May 2019), e1397. DOI:https://doi.org/10.1002/wcms.1397Google ScholarCross Ref
- Layla Azam and J. Michael McIntosh. 2009. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol Sin 30, 6 (June 2009), 783. DOI:https://doi.org/10.1038/APS.2009.47Google ScholarCross Ref
- Angel Baybayon, Jandolf C Villaruz, Enjelyn C Gomez, Lydia M Bajo, and Roger S Tan. 2018. Biological Characterization of Conus textile venom for Medical Applications.Google Scholar
- Daniel Bertrand and Murali Gopalakrishnan. 2007. Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol 74, 8 (October 2007), 1155–1163. DOI:https://doi.org/10.1016/J.BCP.2007.07.011Google ScholarCross Ref
- Marco Biasini, Stefan Bienert, Andrew Waterhouse, Konstantin Arnold, Gabriel Studer, Tobias Schmidt, Florian Kiefer, Tiziano Gallo Cassarino, Martino Bertoni, Lorenza Bordoli, and Torsten Schwede. 2014. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42, Web Server issue (July 2014), W252. DOI:https://doi.org/10.1093/NAR/GKU340Google ScholarCross Ref
- Darlene H. Brunzell, Alexandra M. Stafford, and Claire I. Dixon. 2015. Nicotinic receptor contributions to smoking: insights from human studies and animal models. Curr Addict Rep 2, 1 (March 2015), 33. DOI:https://doi.org/10.1007/S40429-015-0042-2Google ScholarCross Ref
- Rajesh Chawla, Subhash Todi, and Devendra Kumar Agarwal. 2022. Hyponatremia. ICU Protocols: A Stepwise Approach (January 2022), 433–440. DOI:https://doi.org/10.1007/978-81-322-0535-7_55Google ScholarCross Ref
- Lourdes J Cruzs, Victoria de Santoso, Glenn C Zafaralla, Cecilia A Ramiloso, Regina Zeikusll, William R Gray, and Baldomero M Oliveras. 1987. Invertebrate Vasopressin/ Oxytocin Homologs CHARACTERIZATION OF PEPTIDES FROM CONUS GEOGRAPHUS AND CONUS STRIATUS VENOMS*. Journal of Biological Chemistry 262, 33 (June 1987), 15821–15824. DOI:https://doi.org/10.1016/S0021-9258(18)47661-2Google ScholarCross Ref
- Michael D'Andrea and Robert Nagele. 2006. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr Pharm Des 12, 6 (January 2006), 677–684. DOI:https://doi.org/10.2174/138161206775474224Google ScholarCross Ref
- Ankur Dhanik, John S. McMurray, and Lydia E. Kavraki. 2013. DINC: A new AutoDock-based protocol for docking large ligands. BMC Struct Biol 13, SUPPL.1 (November 2013), 1–14. DOI:https://doi.org/10.1186/1472-6807-13-S1-S11/FIGURES/7Google ScholarCross Ref
- Yanli Dong, Yiwei Gao, Shuai Xu, Yuhang Wang, Zhuoya Yu, Yue Li, Bin Li, Tian Yuan, Bei Yang, Xuejun Cai Zhang, Daohua Jiang, Zhuo Huang, and Yan Zhao. 2021. Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2. Cell Rep 37, 5 (November 2021). DOI:https://doi.org/10.1016/J.CELREP.2021.109931Google ScholarCross Ref
- David J. Dooley, Amelie Lupp, Georg Hertting, and Hartmut Osswald. 1988. Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol 148, 2 (March 1988), 261–267. DOI:https://doi.org/10.1016/0014-2999(88)90572-9Google ScholarCross Ref
- Sébastien Dutertre, Daniel Croker, Norelle L. Daly, Åsa Andersson, Markus Muttenthaler, Natalie G. Lumsden, David J. Craik, Paul F. Alewood, Gilles Guillon, and Richard J. Lewis. 2008. Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. Journal of Biological Chemistry 283, 11 (March 2008), 7100–7108. DOI:https://doi.org/10.1074/JBC.M706477200/ATTACHMENT/1D2437A2-3CE6-4414-86DB-B1E667C3C7F4/MMC1.ZIPGoogle ScholarCross Ref
- Sébastien Dutertre, Chris Ulens, Regina Büttner, Alexander Fish, René van Elk, Yvonne Kendel, Gene Hopping, Paul F. Alewood, Christina Schroeder, Annette Nicke, August B. Smit, Titia K. Sixma, and Richard J. Lewis. 2007. AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J 26, 16 (August 2007), 3858–3867. DOI:https://doi.org/10.1038/SJ.EMBOJ.7601785Google ScholarCross Ref
- Jörg Eder and Paul L. Herrling. 2016. Trends in Modern Drug Discovery. Handb Exp Pharmacol 232, (April 2016), 3–22. DOI:https://doi.org/10.1007/164_2015_20Google ScholarCross Ref
- M. Fatehi, S. B. Kombian, and T. M. Saleh. 2005. 17beta-estradiol inhibits outward potassium currents recorded in rat parabrachial nucleus cells in vitro. Neuroscience 135, 4 (2005), 1075–1086. DOI:https://doi.org/10.1016/J.NEUROSCIENCE.2005.07.024Google ScholarCross Ref
- Robert Freedman, Michael Hall, Lawrence E. Adler, and Sherry Leonard. 1995. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38, 1 (July 1995), 22–33. DOI:https://doi.org/10.1016/0006-3223(94)00252-XGoogle ScholarCross Ref
- Kevin J. Gingrich and Larry E. Wagner. 2016. Fast-onset lidocaine block of rat NaV1.4 channels suggests involvement of a second high-affinity open state. Biochimica et Biophysica Acta (BBA) - Biomembranes 1858, 6 (June 2016), 1175–1188. DOI:https://doi.org/10.1016/J.BBAMEM.2016.02.033Google ScholarCross Ref
- Duncan R Groebe, Judith M Dumm, Edwin S Levitan, and Stewart N Abramson. 1995. a-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. MOLECULAR PHARMACOLOGY-NEW YORK THEN BALTIMORE- 48, (1995), 105.Google Scholar
- Simon D. Harding, Jane F. Armstrong, Elena Faccenda, Christopher Southan, Stephen P.H. Alexander, Anthony P. Davenport, Adam J. Pawson, Michael Spedding, and Jamie A. Davies. 2022. The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials. Nucleic Acids Res 50, D1 (January 2022), D1282–D1294. DOI:https://doi.org/10.1093/NAR/GKAB1010Google ScholarCross Ref
- Raymond Hurst, Hans Rollema, and Daniel Bertrand. 2013. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther 137, 1 (2013), 22–54. DOI:https://doi.org/10.1016/J.PHARMTHERA.2012.08.012Google ScholarCross Ref
- Elsie C. Jimenez, A. Grey Craig, Maren Watkins, David R. Hillyard, William R. Gray, Joseph Gulyas, Jean E. Rivier, Lourdes J. Cruz, and Baldomero M. Olivera. 1997. Bromocontryphan: post-translational bromination of tryptophan. Biochemistry 36, 5 (February 1997), 989–994. DOI:https://doi.org/10.1021/BI962840PGoogle ScholarCross Ref
- Elsie C. Jimenéz, Baldomero M. Olivera, William R. Gray, and Lourdes J. Cruz. 1996. Contryphan is a D-tryptophan-containing Conus peptide. J Biol Chem 271, 45 (1996), 28002–28005. DOI:https://doi.org/10.1074/JBC.271.45.28002Google ScholarCross Ref
- Akira Kio Valdorea Kikuchi, Shealtiel William Sta. Maria Chan, Ryan Christian Mailem, Marineil Carillo Gomez, and Lemmuel Lara Tayo. 2022. In silico investigation of oxindole alkaloids from Uncaria perrottetii and Uncaria lanosa f. philippinensis for COVID-19 therapy: binding site prediction and molecular docking. 2022 12th International Conference on Biomedical Engineering and Technology (ICBET) (April 2022), 5–8. DOI:https://doi.org/10.1145/3535694.3535696Google ScholarDigital Library
- Shiva N. Kompella, Hartmut Cuny, Andrew Hung, and David J. Adams. 2015. Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors. Mol Pharmacol 88, 6 (December 2015), 993–1001. DOI:https://doi.org/10.1124/MOL.115.100503Google ScholarCross Ref
- Richard T Layer and J M McIntosh. 2006. Conotoxins: Therapeutic Potential and Application. Marine Drugs 4. DOI:https://doi.org/10.3390/md403119Google ScholarCross Ref
- Eline K.M. Lebbe and Jan Tytgat. 2016. In the picture: Disulfide-poor conopeptides, a class of pharmacologically interesting compounds. Journal of Venomous Animals and Toxins Including Tropical Diseases 22, 1 (November 2016), 1–15. DOI:https://doi.org/10.1186/S40409-016-0083-6/TABLES/14Google ScholarCross Ref
- Enrico Leipold, Alfred Hansel, Baldomero M. Olivera, Heinrich Terlau, and Stefan H. Heinemann. 2005. Molecular interaction of delta-conotoxins with voltage-gated sodium channels. FEBS Lett 579, 18 (July 2005), 3881–3884. DOI:https://doi.org/10.1016/J.FEBSLET.2005.05.077Google ScholarCross Ref
- Richard J. Lewis and Maria L. Garcia. 2003. Therapeutic potential of venom peptides. Nature Reviews Drug Discovery 2003 2:10 2, 10 (October 2003), 790–802. DOI:https://doi.org/10.1038/nrd1197Google ScholarCross Ref
- Ryan Christian Mailem, Shealtiel William Sta. Maria Chan, Akira Kio Valdorea Kikuchi, Marineil Carillo Gomez, and Lemmuel Lara Tayo. 2022. In silico investigation of oxindole alkaloids from Uncaria perrottetii and Uncaria lanosa f. philippinensis for COVID-19 therapy: a ligand affinity and characterization study. 2022 12th International Conference on Biomedical Engineering and Technology (ICBET) (April 2022), 21–25. DOI:https://doi.org/10.1145/3535694.3535699Google ScholarDigital Library
- M. Maillo, M. B. Aguilar, E. Lopéz-Vera, A. G. Craig, G. Bulaj, B. M. Olivera, and E. P. Heimer De La Cotera. 2002. Conorfamide, a Conus venom peptide belonging to the RFamide family of neuropeptides. Toxicon 40, 4 (2002), 401–407. DOI:https://doi.org/10.1016/S0041-0101(01)00176-3Google ScholarCross Ref
- Anaísa Martins Marques, Bárbara Silva Linhares, Rômulo Dias Novaes, Mariella Bontempo Freitas, Mariáurea Matias Sarandy, and Reggiani Vilela Gonçalves. 2020. Effects of the amount and type of carbohydrates used in type 2 diabetes diets in animal models: A systematic review. PLoS One 15, 6 (June 2020), e0233364. DOI:https://doi.org/10.1371/JOURNAL.PONE.0233364Google ScholarCross Ref
- J. G. McGivern and J. F. Worley. 2007. Ion Channels – Voltage Gated. Comprehensive Medicinal Chemistry II 2, (January 2007), 827–875. DOI:https://doi.org/10.1016/B0-08-045044-X/00066-3Google ScholarCross Ref
- Simon K. Michael, Howard K. Surks, Yuepeng Wang, Yan Zhu, Robert Blanton, Michelle Jamnongjit, Mark Aronovitz, Wendy Baur, Kenichi Ohtani, Michael K. Wilkerson, Adrian D. Bonev, Mark T. Nelson, Richard H. Karas, and Michael E. Mendelsohn. 2008. High blood pressure arising from a defect in vascular function. Proc Natl Acad Sci U S A 105, 18 (May 2008), 6702–6707. DOI:https://doi.org/10.1073/PNAS.0802128105/SUPPL_FILE/0802128105SI.PDFGoogle ScholarCross Ref
- Neil S. Millar and Patricia C. Harkness. 2008. Assembly and trafficking of nicotinic acetylcholine receptors (Review). Mol Membr Biol 25, 4 (May 2008), 279–292. DOI:https://doi.org/10.1080/09687680802035675Google ScholarCross Ref
- Sigrid Noreng, Arpita Bharadwaj, Richard Posert, Craig Yoshioka, and Isabelle Baconguis. 2018. Structure of the human epithelial sodium channel by cryo-electron microscopy. Elife 7, (September 2018). DOI:https://doi.org/10.7554/ELIFE.39340Google ScholarCross Ref
- Raymond S Norton and Baldomero M Olivera. 2006. Conotoxins down under. Toxicon 48, 7 (2006), 780–798. DOI:https://doi.org/https://doi.org/10.1016/j.toxicon.2006.07.022Google ScholarCross Ref
- Baldomero M. Olivera. 1997. E.E. Just Lecture, 1996: Conus Venom Peptides, Receptor and Ion Channel Targets, and Drug Design: 50 Million Years of Neuropharmacology. Mol Biol Cell 8, 11 (1997), 2101. DOI:https://doi.org/10.1091/MBC.8.11.2101Google ScholarCross Ref
- Xiaojing Pan, Zhangqiang Li, Qiang Zhou, Huaizong Shen, Kun Wu, Xiaoshuang Huang, Jiaofeng Chen, Juanrong Zhang, Xuechen Zhu, Jianlin Lei, Wei Xiong, Haipeng Gong, Bailong Xiao, and Nieng Yan. 2018. Structure of the human voltage-gated sodium channel Nav1.4 in complex with β1. Science (1979) 362, 6412 (October 2018). DOI:https://doi.org/10.1126/SCIENCE.AAU2486Google ScholarCross Ref
- Diana E. Pankevich, Bruce M. Altevogt, John Dunlop, Fred H. Gage, and Steve E. Hyman. 2014. Improving and Accelerating Drug Development for Nervous System Disorders. Neuron 84, 3 (2014), 546–553. DOI:https://doi.org/https://doi.org/10.1016/j.neuron.2014.10.007Google ScholarCross Ref
- Peng Yuan, Manuel D. Leonetti, Alexander R. Pico, Yichun Hsiung, and Roderick MacKinnon. 2010. Structure of the Human BK Channel Ca2+-Activation Apparatus at 3.0 Å Resolution. Science (1979) 329, 5988 (July 2010), 182–186. DOI:https://doi.org/10.1126/SCIENCE.1190414Google ScholarCross Ref
- BY Pranjalinannajkar, Advisor Lorraine Marsh, and Joseph Morin Cecilia Kovac. 2006. IDENTIFICATION OF THE LIGAND-BINDING SITE OF HUMAN VASOPRESSIN RECEPTOR (VlaR) USING PHYLOGENETIC AND HOMOLOGY MODELING TECHNIQUES 4 fie lot Date SPONSORING COMMITTEE. (2006).Google Scholar
- Marianna Ranieri, Annarita di Mise, Grazia Tamma, and Giovanna Valenti. 2022. Vasopressin Type 2 Receptor Agonists and Antagonists. Comprehensive Pharmacology (January 2022), 656–669. DOI:https://doi.org/10.1016/B978-0-12-820472-6.00148-1Google ScholarCross Ref
- Iván Restrepo-Angulo, Cecilia Bañuelos, and Javier Camacho. 2020. Ion Channel Regulation by Sex Steroid Hormones and Vitamin D in Cancer: A Potential Opportunity for Cancer Diagnosis and Therapy. Front Pharmacol 11, (February 2020), 152. DOI:https://doi.org/10.3389/FPHAR.2020.00152/BIBTEXGoogle ScholarCross Ref
- Alan C. Rigby, Estelle Lucas-Meunier, Dário E. Kalume, Eva Czerwiec, Björn Hambe, Ingrid Dahlqvist, Philippe Fossier, Gérard Baux, Peter Roepstorff, James D. Baleja, Barbara C. Furie, Bruce Furie, and Johan Stenflo. 1999. A conotoxin from Conus textile with unusual posttranslational modifications reduces presynaptic Ca2+ influx. Proc Natl Acad Sci U S A 96, 10 (May 1999), 5758–5763. DOI:https://doi.org/10.1073/PNAS.96.10.5758Google ScholarCross Ref
- S Sardari, Yeganeh Sebti, Soroush Sardari, Hamid Mir, Mohammad Sadeghi, Mohammad Hossein Ghahremani, and Giulio Innamorati. 2015. Study of V2 vasopressin receptor hormone binding site using in silico methods. Res Pharm Sci 10, 4 (2015), 294. Retrieved July 17, 2022 from /pmc/articles/PMC4623618/Google Scholar
- Andreas Scholz. 2007. Nav1.4 Voltage - Gated Sodium Channel. xPharm: The Comprehensive Pharmacology Reference (January 2007), 1–7. DOI:https://doi.org/10.1016/B978-008055232-3.60410-6Google ScholarCross Ref
- Christina I Schroeder and David J Craik. 2012. Therapeutic potential of conopeptides. Future Med Chem 4, 10 (June 2012), 1243–1255. DOI:https://doi.org/10.4155/fmc.12.70Google ScholarCross Ref
- Ki Joon Shon, Baldomero M. Olivera, Maren Watkins, Richard B. Jacobsen, William R. Gray, Christina Z. Floresca, Lourdes J. Cruz, David R. Hillyard, Anette Brink, Heinrich Terlau, and Doju Yoshikami. 1998. mu-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J Neurosci 18, 12 (June 1998), 4473–4481. DOI:https://doi.org/10.1523/JNEUROSCI.18-12-04473.1998Google ScholarCross Ref
- Susan C. Su, Jinsoo Seo, Jen Q. Pan, Benjamin Adam Samuels, Andrii Rudenko, Maria Ericsson, Rachael L. Neve, David T. Yue, and Li Huei Tsai. 2012. Regulation of N-type voltage-gated calcium channels and presynaptic function by cyclin-dependent kinase 5. Neuron 75, 4 (August 2012), 687. DOI:https://doi.org/10.1016/J.NEURON.2012.06.023Google ScholarCross Ref
- Qianhui Sun and Peter Sever. 2020. Amiloride: A review. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System 21, 4 (November 2020). DOI:https://doi.org/10.1177/1470320320975893Google ScholarCross Ref
- Lemmuel L Tayo, Bingwen Lu, Lourdes J Cruz, and John R Yates 3rd. 2010. Proteomic analysis provides insights on venom processing in Conus textile. J Proteome Res 9, 5 (May 2010), 2292–2301. DOI:https://doi.org/10.1021/pr901032rGoogle ScholarCross Ref
- Amber S. Tippens. 2007. Mibefradil. xPharm: The Comprehensive Pharmacology Reference (January 2007), 1–5. DOI:https://doi.org/10.1016/B978-008055232-3.62182-8Google ScholarCross Ref
- Oleg Trott and Arthur J. Olson. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31, 2 (January 2010), 455. DOI:https://doi.org/10.1002/JCC.21334Google ScholarCross Ref
- Sameer Velankar, Younes Alhroub, Anaëlle Alili, Christoph Best, Harry C. Boutselakis, Ségoléne Caboche, Matthew J. Conroy, Jose M. Dana, Glen van Ginkel, Adel Golovin, Swanand P. Gore, Aleksandras Gutmanas, Pauline Haslam, Miriam Hirshberg, Melford John, Ingvar Lagerstedt, Saqib Mir, Laurence E. Newman, Tom J. Oldfield, Chris J. Penkett, Jorge Pineda-Castillo, Luana Rinaldi, Gaurav Sahni, Grégoire Sawka, Sanchayita Sen, Robert Slowley, Alan Wilter Sousa da Silva, Antonio Suarez-Uruena, G. Jawahar Swaminathan, Martyn F. Symmons, Wim F. Vranken, Michael Wainwright, and Gerard J. Kleywegt. 2011. PDBe: Protein Data Bank in Europe. Nucleic Acids Res 39, Database issue (January 2011), D410. DOI:https://doi.org/10.1093/NAR/GKQ985Google ScholarCross Ref
- Andrew C. Wallace, Roman A. Laskowski, and Janet M. Thornton. 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8, 2 (February 1995), 127–134. DOI:https://doi.org/10.1093/PROTEIN/8.2.127Google ScholarCross Ref
- Richard M. Walsh, Soung Hun Roh, Anant Gharpure, Claudio L. Morales-Perez, Jinfeng Teng, and Ryan E. Hibbs. 2018. Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. Nature 557, 7704 (May 2018), 261–265. DOI:https://doi.org/10.1038/S41586-018-0081-7Google ScholarCross Ref
- Hoau Yan Wang, Daniel H.S. Lee, Coralie B. Davis, and Richard P. Shank. 2000. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem 75, 3 (2000), 1155–1161. DOI:https://doi.org/10.1046/J.1471-4159.2000.0751155.XGoogle ScholarCross Ref
Index Terms
- Computational Study on Conus Textile Conopeptides for Mediating Ion Channel Transport
Recommendations
In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitor
mono-H2PyP-AQ in the binding pocket of CDK2.Display Omitted Porphyrin-anthraquinone hybrids were designed and evaluated for their CDK2 inhibitory activity.All porphyrin hybrids interacted with key residues in the ATP-binding site of CDK2.The predicted ...
Inhibitory activity of hibifolin on adenosine deaminase- experimental and molecular modeling study
Display Omitted Adenosine deaminase inhibitors considered as drug leads against malignancies.Hibifoline, a flavonoid from Helicteres isora inhibits ADA.The free energy of binding is -7.21Kcal/mol.In silico studies confirms the mode of binding. Adenosine ...
Antiviral potential of natural compounds against influenza virus hemagglutinin
The antiviral activity of natural compounds against the HA protein of different subtypes of Influenza virus has been investigated using binding free energy and hydrogen bonding interactions.Display Omitted The curucmin derivatives (CI, CII and CIII) ...
Comments